Skip to content

Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions

Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00391300
Enrollment
100
Registered
2006-10-23
Start date
2006-10-31
Completion date
2007-04-30
Last updated
2013-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma (Skin), Non-melanomatous Skin Cancer

Keywords

melanoma, basal cell carcinoma of the skin, squamous cell carcinoma of the skin

Brief summary

RATIONALE: New diagnostic procedures, such as bioelectric field imaging, may help find and diagnose melanoma and other skin cancers. It may also be a less invasive way to check for skin cancer. PURPOSE: This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions.

Detailed description

OBJECTIVES: * To determine if the hand-held Bioelectric Field Imager can be used to measure the electric field in skin of various body surfaces, including face, neck, shoulders, arms, hands, chest, back, legs, and feet, during the course of examination and treatment of patients with suspected malignant skin lesions. * To determine if there is a significant difference between the lateral electric field strength near benign and malignant skin lesions in the same individual. OUTLINE: Patients undergo scanning of their skin lesions and nearby healthy skin using the Bioelectric Field Imager (BFI). The lesions are then biopsied for histological diagnosis. Histological data from the biopsy is correlated with the electric field data from the BFI.

Interventions

PROCEDUREbioelectric field imaging
PROCEDUREbiopsy

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
Eastern Virginia Medical School
Lead SponsorOTHER

Study design

Primary purpose
DIAGNOSTIC

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Suspected malignant skin lesion * Seeking treatment for skin lesion at the VA Medical Center PATIENT CHARACTERISTICS: * Not pregnant * No acute illness, including upper respiratory tract infection or flu that could result in fever * No trauma to the skin lesion area * No prisoners PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Design outcomes

Primary

MeasureTime frame
Use of Bioelectric Field Imager (BFI) in measuring the electric field in skin of various body surfaces
Use of BFI in detecting significant electric field differences between malignant and benign skin lesions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026